OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for April, 2017

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you.

2017-04-29 12:15These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 and more...
2017-04-28 12:15Sarepta CEO Exits Along With a Sanofi Director, So Let's Speculate About a Possible Deal and more...
2017-04-28 00:15Three Biotechs Enter…One Biotech Gains and more...
2017-04-27 12:15AbbVie stock surges 1.5% after first-quarter profit, revenue beats and more...
2017-04-27 00:15Amgen first-quarter profit exceeds Street estimates on lower costs and more...
2017-04-26 12:15J&J, Bayer face first jury trial over blockbuster Xarelto's bleedings risks and more...
2017-04-26 00:15Regeneron’s CEO, CSO saw their compensation slashed in ’16 — but it’s still a jaw-dropping sum and more...
2017-04-25 12:15Novartis beats 1Q profit forecasts and more...
2017-04-25 00:15J&J, Bayer Accused of Hiding Blood-Thinning Drug's Flaws and more...
2017-04-24 12:15Becton Dickinson to acquire Bard in $24B deal and more...
2017-04-23 12:15The 10 hottest medtech startups of 2017 and more...
2017-04-23 00:15Bristol-Myers NASH drug reduces liver fat in midstage study and more...
2017-04-21 12:15GSK told to pay $3M for Chicago attorney's suicide while on generic Paxil and more...
2017-04-21 00:15Biopharma opening up to new ways of partnering on R&D and more...
2017-04-20 12:15Abbott CEO Upbeat Despite Ongoing Merger Headaches and more...
2017-04-20 00:15Report: Price hikes are still driving pharma's earnings growth. Who's most at risk? and more...
2017-04-19 12:15Abbott's profit rises 33 percent after St. Jude Medical deal and more...
2017-04-19 00:15FDA hits the ground running with 12 first-quarter 2017 drug approvals and more...
2017-04-18 12:15Johnson & Johnson tops 1Q profit forecasts, but net dips and more...
2017-04-18 00:15How Pfizer Inc. Makes Most of Its Money and more...
2017-04-17 12:15Chasing a big payday, new drugmakers slightly favor solo launches: Report and more...
2017-04-15 12:15Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch and more...
2017-04-14 12:15Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug and more...
2017-04-14 00:15Novartis' Gilenya patent loss sets MS market up for battle with early generics and more...
2017-04-13 12:15Bristol-Myers to license two drugs to Biogen, Roche and more...
2017-04-13 00:15Organovo Holdings CEO Leaves: Should Investors Be Worried? and more...
2017-04-12 12:153 Big Drugmakers Most Likely to Buy Incyte and more...
2017-04-11 12:15Clinical trial enrollment gets harder as patient populations shrink and more...
2017-04-11 00:15Stada's patience pays off as Cinven, Bain clinch big $5.6B buyout bid and more...
2017-04-10 12:15Roche unit Genentech takes on Pfizer with new lung cancer data and more...
2017-04-10 00:153 Big Biotech Stocks With Big-Time Catalysts and more...
2017-04-09 00:15Gilead Hep C Drugs Get Supplemental FDA Nod and more...
2017-04-07 12:15FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label and more...
2017-04-07 00:1523andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk and more...
2017-04-06 12:15Allergan To Test Botox For Depression Despite Mixed Results and more...
2017-04-06 00:15Intuitive Surgical shares rise amidst takeover rumors and more...
2017-04-05 00:15Racing in lung cancer again (or still), Merck and BMS expand Incyte combo trials and more...
2017-04-04 12:15Mallinckrodt to settle oxycodone diversion case for $35M with Justice Department and more...
2017-04-03 12:15Pfizer's Ibrance Gets FDA Approval for Breast Cancer and more...
2017-04-01 12:15Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much and more...
2017-04-01 00:15FDA Approves Astra's Lung Cancer Drug and more...

 

<< Archive IndexSubscribe >>

Contact Us

Past Issues

Unsubscribe